DCT

1:21-md-03017

In re: Xarelto (Rivaroxaban) ('310) Patent Litigation

Please sign up or log in to access the advanced features of
Ex Parte Enterprise.
Please sign up or log in to access the advanced features of
Ex Parte Enterprise.
General
Filed
12/10/21
Cause Of ActionPatent Infringement
SectorBiotech
StatusOpen
Patent Owner
Operating Company
Nature of Suit835 ANDA
Please sign up or log in to access the advanced features of
Ex Parte Professional.
Judge
Period
PO Win Rate
12/28/21 - now
50%
Plaintiff
Please sign up or log in to access the advanced features of
Ex Parte Professional.
Party
Name
Ratings
L5
A
No Parties
Defendant
Please sign up or log in to access the advanced features of
Ex Parte Professional.
Attorney
Name
Ratings
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
L5
A
No Attorneys